期刊文献+

一例遗传性凝血因子Ⅴ缺乏症发病机制研究 被引量:12

Studies on hereditary deficiency of coagulation factor Ⅴ
原文传递
导出
摘要 目的 研究遗传性凝血因子Ⅴ (FⅤ )缺乏症的发病机制。方法 通过免疫学方法和发色底物法检测血浆和血小板中的FⅤ含量 ,采用PCR产物直接测序和限制性酶切分析FⅤ基因 ,应用分子模建对所鉴定突变的生物结构病理学进行研究。结果 先证者血浆和血小板中FⅤ均缺乏。先证者FⅤ基因第 176 3位核苷酸存在A→C突变 (176 3A→C ,EMBLAJ2 972 5 4)。模建分析表明 ,该突变将导致分子内部形成空洞 ,并可能破坏Tyr5 30与Glu330之间形成的氢键。结论  176 3A→C突变将导致FⅤ稳定性降低 。 Objective To explore the mechanisms of hereditary deficiency of coagulation factor Ⅴ (FⅤ). Methods The amount of FⅤ in plasma and platelets was assayed by immunological and biochemical method, FⅤ gene analysis by PCR product sequencing and restriction enzyme analysing, and the biostructural pathology of the identified mutation by molecular modeling. Results No detectable FⅤ fragments and FⅤ activity were found in the plasma and platelets from the proband of the affected family.His gene analysis revealed a 1?763A→C substitution in a FⅤ allele gene. The mutation might cause the loss of the hydrogen bond between conservative Tyr530 and Glu330, and form a cavity in the protein core. Conclusion The 1?763A→C mutation might cause the instability of FⅤ and be the important mechanism for the hereditary deficiency of FⅤ.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2001年第9期453-456,共4页 Chinese Journal of Hematology
关键词 凝血因子V 基因突变 分子模拟 遗传性凝血因子V缺乏症 发病机制 Coagulation factor Ⅴ Gene mutation Molecular modeling
  • 相关文献

参考文献2

二级参考文献1

共引文献6

同被引文献111

  • 1乐玮,于金德,陆林,陶蓉,尤蓓,蔡煦,曹文俊,黄薇,何汝敏,陈竺,龚兰生.Arg485Lys polymorphism of factor Ⅴ increases the risk of coronary artery disease in a Chinese population[J].Chinese Medical Journal,2000(11):3-6. 被引量:2
  • 2罗佳滨,关月,马洪星,李少英,李月秋,吕学诜.凝血因子V基因点突变1691 A在不同种族人群中的分布[J].中华医学遗传学杂志,1996,13(4):219-220. 被引量:17
  • 3Van Wijk R, Nieuwenhuis K, Vanden M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood, 2001, 98:358-367.
  • 4Chen TY, Lin TM, Chen HY,et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency:molecular characterization by expression of the recombinant protein. Thromb Haemost, 2005,93(3):614-615.
  • 5Seanavini D, Girelli D, Lunghi B,et al. Modulation of factor V levels in plasma by polymorphisms in the C2 domain. Arterioscler Thromb Vase Biol, 2004,24(1):200-206.
  • 6Soria JM, Blangero J, Souto JC, et al. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties. Hum Genet, 2002,111:59-65.
  • 7Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.
  • 8Schrijver I, Hong DW, Mandle L, et al, High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. Thromb Haemost,2005,g3(3) :610-611.
  • 9Schrijver I, Koerper MA, Jones CD, et al, Homozygous factor V splice site mutation associated with severe factor V deficiency.Blood, 2002,99 : 3063-3065.
  • 10Asselta R, Montefusco MC, Duga S , et al. Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain. J Thromb Haemost, 2003,1:1237-1244.

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部